ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 191 filers reported holding ARGENX SE in Q1 2021. The put-call ratio across all filers is 0.77 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,654,335 | +181.4% | 3,365 | +113.2% | 0.16% | +138.2% |
| Q1 2023 | $587,931 | -36.4% | 1,578 | -35.3% | 0.07% | -43.8% |
| Q2 2022 | $924,000 | +69.5% | 2,440 | +56.7% | 0.12% | -6.2% |
| Q4 2021 | $545,000 | -3.9% | 1,557 | -17.3% | 0.13% | -10.4% |
| Q2 2021 | $567,000 | -12.4% | 1,883 | -20.7% | 0.14% | -16.8% |
| Q1 2021 | $647,000 | – | 2,375 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SAL Trading, LLC | 36,100 | $17,747,843 | 24.88% |
| Artia Global Partners LP | 49,238 | $24,206,878 | 10.06% |
| Paradigm Biocapital Advisors LP | 261,443 | $128,533,222 | 8.72% |
| Darwin Global Management, Ltd. | 45,615 | $22,425,702 | 7.89% |
| Avoro Capital Advisors LLC | 1,000,000 | $491,630,000 | 7.67% |
| Bellevue Group AG | 911,530 | $448,135,494 | 7.22% |
| Eagle Health Investments LP | 64,400 | $31,660,972 | 6.98% |
| DCF Advisers, LLC | 22,000 | $10,815,860 | 5.89% |
| SAL Trading, LLC | 8,149 | $4,006,293 | 5.62% |
| RTW INVESTMENTS, LP | 507,195 | $249,352,278 | 5.26% |